Publications

5808 Results

Summary of a joint meeting between the Southwest Oncology Group and the Japanese Clinical Trial Consortium.

Authors
ML Rothenberg;C Coltman, Jr;M Fukushima
Journal / Conference
JCRCO 119:564-567
Year
1993

Pre-operative irradiation plus radical cystectomy versus surgery alone for invasive bladder cancer: Final results of a randomized, prospective Southwest Oncology Group study.

Authors
JA Smith Jr;ED Crawford;BL Blumenstein;J Paradelo;BR Herschman
Journal / Conference
American Urological Association Inc. 149:316A(#415)
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8221 (INT-0007)

Phase II trial of DTIC in patients with metastatic carcinoid tumors: A Southwest Oncology Group study.

Authors
A Bhatia;RF Peterson;C Tangen;T Fleming;J Macdonald;RM Bukowski
Journal / Conference
ASCO 12:222(#677)
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8411

Adjuvant continuous infusion 5FU (CI 5FU), whole abdominal radiation and tumor bed boost in dukes C2 colon carcinoma: A Southwest Oncology Group pilot study.

Authors
C Fabian;S Giri;N Estes;C Tangen;E Poplin;S Vogel;W Goodwin;T Fleming
Journal / Conference
ASCO 12:199(#588)
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8572

Recognition and salvage of the patient with recurrent colon cancer.

Authors
C Moertel;T Fleming;J Macdonald;D Haller;J Laurie;C Tangen
Journal / Conference
ASCO 12:224(#688)
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)

A randomized comparison of bacillus calmette-guerin and mitomycin C prophylaxis in stage TA and T1 transitional cell carcinoma of the bladder.

Authors
DL Lamm;ED Crawford;B Blumenstein;J Crissman;R deVere White;M Wolf;B Lowe;M Sarosdy;P Schellhammer;A Sagalowsky;J Smith;HB Grossman;R Flanigan;T Moon;C Brendler;C Coltman, Jr
Journal / Conference
American Urological Association 149:4(#275)
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8795 (INT-0094) (EST-1888)

The role of alpha interferon (rINFa2a) maintenance in patients with limited stage SCLC responding to con-current chemoradiation: A Southwest Oncology Group study.

Authors
K Kelly;PA Bunn Jr;M Hazuka;K Beasley;J Crowley;R Livingston
Journal / Conference
ASCO 12:330(#1099)
Year
1993
Research Committee(s)
Lung
Study Number(s)
SWOG-8812

A phase II trial of continuous infusion recombinant interleukin-2 (rIL-2) in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.

Authors
RP Whitehead;MK Wolf;DL Solanki;P Benedetto;RC Flanigan;ED Crawford
Journal / Conference
ASCO 12:253(#799)
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8824

Fluorouracil (5-FU) schedules and modulation in advanced colorectal cancer (CRC): A Southwest Oncology Group screening trial.

Authors
CG Leichman;TR Fleming;FM Muggia;B Ardalan;J Doroshow;C Tangen;J Macdonald
Journal / Conference
ASCO 12:198(#583)
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8905

The addition of tamoxifen (T) to dacarbazine (D) and cisplatin (C) in a Southwest Oncology Group phase II trial (8921) in metastatic malignant melanoma (MMM) stage IV.

Authors
L Flaherty;PY Liu;D Daniels;V Sondak
Journal / Conference
ASCO 12:394(#1349)
Year
1993
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8921